Inhibition of HSP90A with AUY922 robustly dampened AKT phosphorylation level and expression of the effectors in NANOG signaling, such as MCL-1, Cyclin A, and TCL1A across all tested cancer cells (Fig. 5a). This evidence concerns the gene CCNA2 and cancer.